Search

Sartorius Stedim Biotech.

Uždarymo kaina

SektoriusFinansų sektorius

192.4 -1.38

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

190.6

Max

195.3

Pagrindiniai rodikliai

By Trading Economics

Pajamos

4.9M

93M

Pardavimai

4.2M

766M

P/E

Sektoriaus vid.

60.332

22.368

Pelnas, tenkantis vienai akcijai

1.25

Dividendų pajamingumas

0.37

Pelno marža

12.146

Darbuotojai

10,477

EBITDA

9.2M

240M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+19.66% upside

Dividendai

By Acuity

Dividendų pajamingumas

Sektoriaus vid.

0.37%

4.40%

Kitas uždarbis

2026-10-22

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

134M

18B

Ankstesnė atidarymo kaina

193.78

Ankstesnė uždarymo kaina

192.4

Sartorius Stedim Biotech. Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-21 22:01; UTC

News

Cytek Biosciences shares are lower in after-market hours following a jury's $56 million damages award to Beckman Coulter for patent infringement.

2026-08-21 20:07; UTC

News
Social Media

Microsoft shares are higher, supported by bullish options activity and a reaffirmed AAA rating from Moody's. The company is part of a $615 billion AI investment group.

2026-08-21 20:07; UTC

Social Media
News

Palantir Technologies shares are higher today amid increased options trading and positive sentiment, with Deutsche Bank reiterating a $200 price target.

2026-08-21 20:07; UTC

News

Aflac shares are lower today as Japan Post sold 12,700 shares, contributing to negative sentiment amid broader market declines since Thursday's close.

2026-08-21 20:07; UTC

News

United Parcel Service shares are trading lower as Zacks cuts Q3 EPS estimate to $1.60. Susquehanna raises target price to $120, maintaining a neutral rating.

2026-08-21 20:07; UTC

News

Barclays maintains an Overweight rating on Hims & Hers Health, lowering its price target to $35. Shares are trading higher amid positive market sentiment.

2026-08-21 20:07; UTC

News
Correlated Moves

The USD/SEK is trading lower today, continuing a decline since Thursday's close. Earlier in the session, the dollar rebounded from a session low.

2026-08-21 20:06; UTC

News

Nu Holdings is higher today, buoyed by a rise in Bitcoin prices following the U.S. Treasury's announcement to double long-dated bond buybacks.

2026-08-21 20:06; UTC

News
Correlated Moves

Gold prices are rising, reaching a near three-month high, driven by U.S. Treasury bond buybacks and President Trump's shift in Iran policy.

2026-08-21 20:06; UTC

Correlated Moves
News

First Western Financial promotes Brian Weldon to Regional President and Bryce Parietti and Rob Miles to Market Presidents, with shares trading higher today.

2026-08-21 20:06; UTC

News
Social Media

JPMorgan raises Okta price target to $165; shares modestly higher.

2026-08-21 20:06; UTC

News

Liquidity Services shares are higher after announcing CEO Bill Angrick's presentation at the Midwest IDEAS Investor Conference on August 26, 2026, in Chicago.

2026-08-21 20:06; UTC

News

Palo Alto Networks shares are higher following multiple analyst price target increases, including Cantor Fitzgerald's raise to $425 from $340.

2026-08-21 20:06; UTC

News

Citizens Inc shares are lower today, continuing a decline since Thursday amid broader market downturns. The stock remains below its 20-day moving average.

2026-08-21 20:06; UTC

News
Social Media

Stoke Therapeutics shares rise following analyst reinstatement with Overweight rating and $40 price target, amid positive sentiment for zorevunersen’s phase III EMPEROR trial.

2026-08-21 20:06; UTC

News

T Rowe Price shares are lower as the company pursues its acquisition of F/M Investments, which manages over $10 billion in ETF assets.

2026-08-21 20:06; UTC

News

Salesforce Inc is higher as investor interest grows ahead of its August 26 earnings report, with a revenue target of $11.3 billion for Q2.

2026-08-21 20:06; UTC

News
Correlated Moves

EUR/SGD is trading lower despite a positive HCOB Eurozone Manufacturing PMI of 52.8, which exceeded forecasts and previous figures.

2026-08-21 20:06; UTC

News
Correlated Moves

Texas Instruments shares reached a 16-week low at $264.73, continuing a decline despite a year-over-year increase. Broader semiconductor sector weakness may be influencing sentiment.

2026-08-21 20:06; UTC

News
Correlated Moves

AXIS Capital Holdings shares are lower today, reflecting broader market trends and a decline in Hartford Financial Services Group. The overall market remains flat since Thursday.

2026-08-21 20:06; UTC

News

Clean Harbors sees earnings estimates raised to $3.14 per share, but shares are trading lower amid a broader market decline.

2026-08-21 20:06; UTC

News
Event
Correlated Moves

Elastic NV trades roughly flat since Thursday's close.

2026-08-21 20:06; UTC

Correlated Moves
News

SmartFinancial Inc shares trade near unchanged as the Russell 2000 Index rises. Analyst ratings show a consensus score of 2.57, reflecting stable sentiment.

2026-08-21 20:06; UTC

News

Church & Dwight is higher today, driven by gains in the Household Products sector. The company announced its participation in the Barclays Global Consumer Staples Conference.

2026-08-21 20:06; UTC

News

OPKO Health shares rise as Zacks improves Q3 2026 loss estimate to $0.06, despite Barrington's downgrade and mixed analyst ratings.

2026-08-21 20:06; UTC

News

A U.S. appeals court ruling allows Delta Air Lines' joint venture with Aeromexico to continue, boosting investor sentiment and driving shares higher.

2026-08-21 20:06; UTC

News
Correlated Moves

Olin Corp's shares are declining today amid broader market trends. Analyst sentiment remains cautious, with a consensus recommendation of "Reduce" from sixteen firms.

2026-08-21 20:06; UTC

News

Warner Music Group reports 11.3% streaming growth in Q2 2026, narrowing the gap with Spotify. Shares are advancing amid positive market sentiment.

2026-08-21 20:06; UTC

News
Correlated Moves

Gold prices are advancing, reaching a near three-month high, driven by U.S. Treasury bond buybacks and reduced Middle East conflict concerns.

2026-08-21 20:06; UTC

News
Social Media

Semtech shares are declining despite BMO Capital's Outperform rating and $155 price target. Earlier, the stock peaked before reversing direction.

Akcijų palyginimas

Kainos pokytis

Sartorius Stedim Biotech. Prognozė

Kainos tikslas

By TipRanks

19.66% į viršų

12 mėnesių prognozė

Vidutinis 233.33 EUR  19.66%

Aukščiausias 260 EUR

Žemiausias 210 EUR

Remiantis 6 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Sartorius Stedim Biotech. kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

6 ratings

6

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Sartorius Stedim Biotech.

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.
help-icon Live chat